These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 31983407)

  • 1. The impact of cirrhosis and MELD score on postoperative morbidity and mortality among patients selected for liver resection.
    Zaydfudim VM; Turrentine FE; Smolkin ME; Bauer TB; Adams RB; McMurry TL
    Am J Surg; 2020 Sep; 220(3):682-686. PubMed ID: 31983407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing Outcomes of Minimally Invasive and Open Hepatectomy for Primary Liver Malignancies in Patients with Low-MELD Cirrhosis.
    Wehrle CJ; Woo K; Raj R; Chang J; Stackhouse KA; Dahdaleh F; Augustin T; Joyce D; Simon R; Kim J; Aucejo F; Walsh RM; Kwon DCH; Pawlik TM; Naffouje SA
    J Gastrointest Surg; 2023 Nov; 27(11):2424-2433. PubMed ID: 37620660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of chronic liver disease on the risk assessment of ACS NSQIP morbidity and mortality after hepatic resection.
    Zaydfudim VM; Kerwin MJ; Turrentine FE; Bauer TW; Adams RB; Stukenborg GJ
    Surgery; 2016 May; 159(5):1308-15. PubMed ID: 26747226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Model for End-stage Liver Disease score fails to predict perioperative outcome after hepatic resection for hepatocellular carcinoma in patients without cirrhosis.
    Teh SH; Sheppard BC; Schwartz J; Orloff SL
    Am J Surg; 2008 May; 195(5):697-701. PubMed ID: 18367132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis.
    Cucchetti A; Ercolani G; Vivarelli M; Cescon M; Ravaioli M; La Barba G; Zanello M; Grazi GL; Pinna AD
    Liver Transpl; 2006 Jun; 12(6):966-71. PubMed ID: 16598792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Esophageal Cancer Surgery for Patients with Concomitant Liver Cirrhosis: A Single-Center Matched-Cohort Study.
    Valmasoni M; Pierobon ES; De Pasqual CA; Zanchettin G; Moletta L; Salvador R; Costantini M; Ruol A; Merigliano S
    Ann Surg Oncol; 2017 Mar; 24(3):763-769. PubMed ID: 27704371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a nomogram to predict outcome after liver resection for hepatocellular carcinoma in Child-Pugh B cirrhosis.
    Berardi G; Morise Z; Sposito C; Igarashi K; Panetta V; Simonelli I; Kim S; Goh BKP; Kubo S; Tanaka S; Takeda Y; Ettorre GM; Wilson GC; Cimino M; Chan CY; Torzilli G; Cheung TT; Kaneko H; Mazzaferro V; Geller DA; Han HS; Kanazawa A; Wakabayashi G; Troisi RI
    J Hepatol; 2020 Jan; 72(1):75-84. PubMed ID: 31499131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Model for End-Stage Liver Disease Sodium as a Predictor of Surgical Risk in Cirrhotic Patients With Ascites.
    Maassel NL; Fleming MM; Luo J; Zhang Y; Pei KY
    J Surg Res; 2020 Jun; 250():45-52. PubMed ID: 32018142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hierarchic Interaction of Factors Associated With Liver Decompensation After Resection for Hepatocellular Carcinoma.
    Citterio D; Facciorusso A; Sposito C; Rota R; Bhoori S; Mazzaferro V
    JAMA Surg; 2016 Sep; 151(9):846-53. PubMed ID: 27248425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The utility of the MELD score in predicting mortality following liver resection for metastasis.
    Fromer MW; Aloia TA; Gaughan JP; Atabek UM; Spitz FR
    Eur J Surg Oncol; 2016 Oct; 42(10):1568-75. PubMed ID: 27365199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recovery from liver failure after hepatectomy for hepatocellular carcinoma in cirrhosis: meaning of the model for end-stage liver disease.
    Cucchetti A; Ercolani G; Cescon M; Ravaioli M; Zanello M; Del Gaudio M; Lauro A; Vivarelli M; Grazi GL; Pinna AD
    J Am Coll Surg; 2006 Nov; 203(5):670-6. PubMed ID: 17084328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Albumin-Bilirubin Score vs Model for End-Stage Liver Disease in Predicting Post-Hepatectomy Outcomes.
    Fagenson AM; Gleeson EM; Pitt HA; Lau KN
    J Am Coll Surg; 2020 Apr; 230(4):637-645. PubMed ID: 31954813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indication of the extent of hepatectomy for hepatocellular carcinoma on cirrhosis by a simple algorithm based on preoperative variables.
    Cescon M; Cucchetti A; Grazi GL; Ferrero A; Viganò L; Ercolani G; Zanello M; Ravaioli M; Capussotti L; Pinna AD
    Arch Surg; 2009 Jan; 144(1):57-63; discussion 63. PubMed ID: 19153326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for mortality after surgery in patients with cirrhosis.
    Teh SH; Nagorney DM; Stevens SR; Offord KP; Therneau TM; Plevak DJ; Talwalkar JA; Kim WR; Kamath PS
    Gastroenterology; 2007 Apr; 132(4):1261-9. PubMed ID: 17408652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and Risk Factors of Postoperative Mortality and Morbidity After Elective Versus Emergent Abdominal Surgery in a National Sample of 8193 Patients With Cirrhosis.
    Johnson KM; Newman KL; Green PK; Berry K; Cornia PB; Wu P; Beste LA; Itani K; Harris AHS; Kamath PS; Ioannou GN
    Ann Surg; 2021 Oct; 274(4):e345-e354. PubMed ID: 31714310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of Model for End-Stage Liver Disease (MELD) score in predicting outcomes for lower extremity bypass.
    Krafcik BM; Farber A; Eslami MH; Kalish JA; Rybin D; Doros G; Shah NK; Siracuse JJ
    J Vasc Surg; 2016 Jul; 64(1):124-30. PubMed ID: 26994957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morbidity and mortality related to non-hepatic surgery in patients with liver cirrhosis: a systematic review.
    de Goede B; Klitsie PJ; Lange JF; Metselaar HJ; Kazemier G
    Best Pract Res Clin Gastroenterol; 2012 Feb; 26(1):47-59. PubMed ID: 22482525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mortality in hepatectomy: Model for End-Stage Liver Disease as a predictor of death using the National Surgical Quality Improvement Program database.
    Ross SW; Seshadri R; Walters AL; Augenstein VA; Heniford BT; Iannitti DA; Martinie JB; Vrochides D; Swan RZ
    Surgery; 2016 Mar; 159(3):777-92. PubMed ID: 26474653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occurrence of cirrhosis-related complications is a time-dependent prognostic predictor independent of baseline model for end-stage liver disease score.
    Huo TI; Lin HC; Lee FY; Hou MC; Lee PC; Wu JC; Chang FY; Lee SD
    Liver Int; 2006 Feb; 26(1):55-61. PubMed ID: 16420510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Between Portosystemic Shunts and Increased Complications and Mortality in Patients With Cirrhosis.
    Simón-Talero M; Roccarina D; Martínez J; Lampichler K; Baiges A; Low G; Llop E; Praktiknjo M; Maurer MH; Zipprich A; Triolo M; Vangrinsven G; Garcia-Martinez R; Dam A; Majumdar A; Picón C; Toth D; Darnell A; Abraldes JG; Lopez M; Kukuk G; Krag A; Bañares R; Laleman W; La Mura V; Ripoll C; Berzigotti A; Trebicka J; Calleja JL; Tandon P; Hernandez-Gea V; Reiberger T; Albillos A; Tsochatzis EA; Augustin S; Genescà J;
    Gastroenterology; 2018 May; 154(6):1694-1705.e4. PubMed ID: 29360462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.